Homeopathic treatment of Headache in adults

INTERVENTION: Intervention1: Individualized homoeopathic medicines in individualized dosage and concomitant care: The enrolled patients of migraine will be treated with IHMs selected using Boenninghausen’s hexameter while using BCR to determine the most appropriate remedy. The indicated homoeopathic medication will be administered in centesimal potencies as part of the proposed intervention, as decided appropriate to the case or condition. Each dose, measured in centesimal scale, must contain 4 cane sugar globules (no. 40) medicated with the indicated drug (kept in 90% v/v ethanol) to be consumed orally on clean tongue and in empty stomach; dosage and repetition will be given depending upon the individual case requirement. It will be advised to patients not to handle the globules and not to consume any food, liquids, smoke or brush their teeth within 30 minutes of taking the globules and will be asked to suck the globules instead of simply swallowing them. Every time, a single, individualized medication will be prescribed taking into account presenting totality of symptom, clinical history details, constitutional features, miasmatic expressions, repertorization using BCR with the aid of HOMPATH software in each case with due consultation of Materia Medica and due consensus among three homoeopaths. A firm accredited by Good Manufacturing Practices (GMP) will supply all medications and other items. Based on the principles of classical homoeopathy, provisions will be made for changing the medications or potencies and alter the dosage in subsequent visits as needed and such instances will be compared between groups. Concomitant care measures include lifestyle changes, yoga, dietary management. Route of administration: per oral. Duration of therapy: 3 months. Control Intervention1: Identi CONDITION: Health Condition 1: G439‐ Migraine, unspecified PRIMARY OUTCOME: Migraine Disability Assessment questionnaire (MIDAS)Timepoint: Baseline and every month up to 3 months SECONDARY OUTCOME: 36‐Item Short Form Health Survey questionnaire (SF‐36)Timepoint: Baseline and every month up to 3 months Measures Yourself Medical Outcome Profile version 2 questionnaire (MYMOP‐2)Timepoint: Baseline and every month up to 3 months INCLUSION CRITERIA: 1. Patients of age group 18‐50 years. 2. Either se Xor transgender. 3. Patients having migraine (ICD 10 code G43) as per the criteria of International Classification of Headache Disorders (ICHD‐3) for migraine. I. Migraine with aura a. Headache attacks lasting 4 to 72 hours (untreated or unsuccessfully treated) b. Headache has at least 2 of the following characteristics: i. Unilateral location ii. Pulsating quality iii. Moderate‐to‐severe pain intensity iv. Aggravation by or causing avoidance of routine physical activity (walking or climbing stairs) c. During a headache, at least 1 of the following: i. Nausea and/or vomiting ii. Photophobia and phonophobia II. Migraine with aura a. 1 or more of the fully reversible aura symptoms mentioned below: i. Visual ii. Sensory iii. Speech and language <